about
Strategies for Management of the Early Chronic Obstructive Lung DiseaseClinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of lifeThe efficacy and safety of triple inhaled treatment in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis using Bayesian methodsEffect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosisLung function decline in subjects with and without COPD in a population-based cohort in Latin-America.The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial.Non-pharmacological management of chronic obstructive pulmonary disease.Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis.Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients.Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary diseaseGeroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease.Age-related annual decline of lung function in patients with COPDOutcome of Inhaler Withdrawal in Patients Receiving Triple Therapy for COPD.Bronchodilator response in adults with bronchiectasis: correlation with clinical parameters and prognostic implicationsFeasibility of spirometry in primary care to screen for COPD: a pilot study.Indacaterol: a comprehensive review.The Isosteroid Alkaloid Imperialine from Bulbs of Fritillaria cirrhosa Mitigates Pulmonary Functional and Structural Impairment and Suppresses Inflammatory Response in a COPD-Like Rat ModelIndividualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?Pulmonary rehabilitation coupled with negative pressure ventilation decreases decline in lung function, hospitalizations, and medical cost in COPD: A 5-year study.Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials.How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationNew developments in the assessment of COPD: early diagnosis is key.Natural course of early COPD.Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor useEvaluation of WO2012080456 and WO2012080457; Boheringer Ingleheim's first CXCR2 antagonists.Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?Voluntary lung function screening to reveal new COPD cases in southern Italy.Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease.Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.Individual FEV1 Trajectories Can Be Identified from a COPD Cohort.Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study.Prevalence of chronic obstructive pulmonary disease in independent community-dwelling older adults: The Fujiwara-kyo study.Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.The clinical and economic burden of chronic obstructive pulmonary disease in the USA.Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.
P2860
Q26739008-B8763707-F902-4DAE-AF30-7E0D15F6BDE2Q26801134-F57A45AA-74AF-4BA8-8B07-7638133FE8D6Q28085193-CDE4EC71-D3D2-49B9-B109-27EE67F27C8EQ28394883-60DE0B29-850A-4EC4-A6BC-4939C2533602Q33637995-D03A464B-682D-4787-90FB-79EA87824A1EQ34216188-1D617953-9314-4AE3-B455-65B1CDAB95BEQ35090155-344FD795-81B8-4BF0-9CB9-8300B57A849FQ35184982-D109A577-0506-41EB-AF4F-4232184318F8Q35290234-DA8BD473-786D-443E-A624-D6505CBA3FA0Q35735393-0C9DB88A-3DFA-4D0F-A28F-A6CA14E8F326Q35774959-A94F89B1-11C1-4158-A67A-2241E51888A4Q35884573-95381D36-BCB3-451A-BE7D-A4E5ADCA2AB0Q36052363-92E662E1-8219-4573-A1F7-8AD4B9DAD3A2Q36283905-B174DCE8-6B84-40D8-8937-141845558519Q36425669-F41F938C-6E00-4632-9D91-F6CFCFDDAD00Q36431478-5FFEAB6B-82A8-4A0E-BB97-1A89D6B262B5Q36540268-9F9E0F5A-B612-4997-8673-6A10D62BE316Q36597209-3C0A9066-50B5-4FA9-8D67-55F36602F0F1Q37057061-75738A4F-37FF-406E-B406-585A4C9D09F8Q37147437-FB0A00BD-C90A-4E06-B3DF-F0CA43BE3D60Q37158517-FEEDFE38-D254-4F18-8EEF-666C3DB05702Q37354827-37180FF4-960B-4FEE-B9DC-1BDBDC152109Q37447593-8A4D552D-FC3F-4720-9ED2-233A3E3C27F0Q37609903-3B82E3FC-7AD1-4A5C-93E7-40A3894DA0A8Q37616657-5D020F4E-BCB2-4257-8408-4348743C319AQ37664778-2ED7EA0E-6618-4BF9-9AF5-E8B707CDD945Q37678020-39F74783-9E1F-4E4C-8756-A5FBD44F701FQ38074216-0BADB951-DA80-4361-9B6E-150F116CCE25Q38571581-88E3D6EE-D032-495A-9DCF-063FBE29BEAEQ38661405-CD56FBFB-974B-477D-973C-2DEF2D0061B2Q39462715-4ADBD9D8-23AA-4AC8-96F2-9D2D976FAA50Q39609265-348FC9DE-F666-481E-B88A-2682C99EA255Q39674585-20C0144B-0566-4972-9601-6602602594A2Q40065171-EF792CE4-F672-428D-8F35-F46102714585Q40109069-4AD093D5-687B-42AF-8A1D-E6CAD747A3B1Q40157587-624B12BF-A81D-4D56-BB28-10D5E49805E3Q40902162-F58627FD-3033-4E1E-B8ED-82964E07ADB1Q41548699-E79B32FE-3581-4E42-AF90-383498AFBF5CQ41633769-E4264B90-267B-4574-A5C9-4CDAB3081457Q41711651-495A190B-2C07-42D5-931B-AB73904D215E
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Lung function decline in COPD
@ast
Lung function decline in COPD
@en
Lung function decline in COPD
@nl
type
label
Lung function decline in COPD
@ast
Lung function decline in COPD
@en
Lung function decline in COPD
@nl
prefLabel
Lung function decline in COPD
@ast
Lung function decline in COPD
@en
Lung function decline in COPD
@nl
P2860
P3181
P356
P1476
Lung function decline in COPD
@en
P2093
Claudio Tantucci
Denise Modina
P2860
P3181
P356
10.2147/COPD.S27480
P407
P577
2012-01-01T00:00:00Z
2012-02-09T00:00:00Z